A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhidrosis

Trial Profile

A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhidrosis

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2018

At a glance

  • Drugs Glycopyrrolate (Primary)
  • Indications Hyperhidrosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ATMOS-2
  • Sponsors Dermira
  • Most Recent Events

    • 17 Feb 2018 According to the Dermira media release, from two phase III (ATMOS-1 & ATMOS-2) studies were presented during the Late-Breaking Research Forums at the 76th Annual Meeting of the American Academy of Dermatology (AAD).
    • 17 Feb 2018 Results from ATMOS-1 and ATMOS-2 trials published in a Dermira media release.
    • 12 Feb 2018 According to Dermira media release, data from two phase III (ATMOS-1 & ATMOS-2) studies will be presented at the 76th Annual Meeting of the American Academy of Dermatology (AAD).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top